Biopharma Patient Support Program Deployment and Hypercare
Launching a patient support program in biopharma is a significant milestone, but it’s not the finish line. The real work starts the moment the first patient is enrolled. Those first
Launching a patient support program in biopharma is a significant milestone, but it’s not the finish line. The real work starts the moment the first patient is enrolled. Those first
Biomedical research is about pushing the boundaries of human knowledge, today those breakthroughs rely as much on digital infrastructure as they do laboratory innovation. Data sets that once lived in
Patient expectations have changed. From ordering groceries to managing appointments, digital convenience is now the norm. That shift doesn’t stop at healthcare, especially when it comes to how patients interact
The pharmaceutical industry is in the midst of a profound transformation, shifting its focus from solely developing and selling drugs to providing comprehensive patient-centric care. This paradigm shift is largely
Every drug launch is a race against time. Synchronizing a Patient Support Program (PSP) with a regulatory milestone, especially the PDUFA review deadline, can make or break early patient engagement.
It’s no secret: starting a therapy is one thing; staying on it is another. For millions of patients navigating complex medication regimens, support can make the difference between consistency and
Artificial Intelligence (AI) stands as one of the most influential technological advancements reshaping the healthcare industry today. By driving new levels of operational efficiency, innovation, and personalized care, AI in
A patient support program (PSP) is a moving target in today’s biopharma industry. A new therapy is introduced. A reimbursement requirement shifts. A regulatory update lands out of nowhere. Amid
When it comes to staffing a call center, from clinical research screening to a patient liaison-type service for a commercial drug, it could be tempting for companies to seek out
Nurse educators play a vital role in supporting individuals with rare and orphan diseases, which often affect fewer than 200,000 people in the U.S. and 7,000 unique diseases worldwide. These